Company intelligence / Profile preview

TMM Group

Frankenmuth, Michigan, United Statestmm-group.eu ↗

Ownership: Private
Development stage: Other

Overview

TMM Group operates primarily as a venture capital firm focused on early-stage investments in biotechnology and emerging health technologies. Through its arm "TMM Ventures," the company supports startups developing plant-based pharmaceutical therapeutics and other innovative solutions targeting neurological functions (memory/appetite/pain/stress), metabolism/energy balance/anxiety/immunity/sleep. It provides seed or early-stage funding with global reach via high-net-worth individuals/institutional investors/resources for next-level growth. No direct clinical results are reported for the group itself.

Industry: Investors

Beyond the preview

Go deeper on TMM Group.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on TMM Group.

Explore the full profile